Patient perceived barriers to exercise and their clinical associations in difficult asthma.

Asthma barriers exercise psychology

Journal

Asthma research and practice
ISSN: 2054-7064
Titre abrégé: Asthma Res Pract
Pays: England
ID NLM: 101670236

Informations de publication

Date de publication:
2020
Historique:
received: 12 04 2020
accepted: 02 06 2020
entrez: 16 6 2020
pubmed: 17 6 2020
medline: 17 6 2020
Statut: epublish

Résumé

Exercise is recommended in guidelines for asthma management and has beneficial effects on symptom control, inflammation and lung function in patients with sub-optimally controlled asthma. Despite this, physical activity levels in patients with difficult asthma are often impaired. Understanding the barriers to exercise in people with difficult asthma is crucial for increasing their activity, and in implementing successful, disease modifying, and holistic approaches to improve their health. 62 Patients within the WATCH Difficult Asthma Cohort (Southampton, UK) completed an Exercise Therapy Burden Questionnaire (ETBQ). The results were analyzed with contemporaneous asthma-related data to determine relationships between perceived exercise barriers and asthma and comorbidity characteristics. Patients were reflective of a difficult asthma cohort, 66% were female, and 63% were atopic. They had a high BMI (median [inter-quartile range]) of 29.3 [25.5-36.2], age of 53.5 [38.75, 65.25], impaired spirometry with FEV1 73% predicted [59.5, 86.6%] and FEV/FVC ratio of 72 [56.5, 78.0] and poor symptom control, as defined by an Asthma Control Questionnaire (ACQ6) result of 2.4 [1.28, 3.2]. A high perceived barriers to exercise score was significantly correlated with increased asthma symptoms ( In difficult asthma, perceived barriers to exercise are related to symptom burden and psychological morbidity. Therefore, exercise interventions combined with psychological input such as CBT to restructure thought processes around these perceived barriers may be useful in facilitating adoption of exercise.

Sections du résumé

BACKGROUND BACKGROUND
Exercise is recommended in guidelines for asthma management and has beneficial effects on symptom control, inflammation and lung function in patients with sub-optimally controlled asthma. Despite this, physical activity levels in patients with difficult asthma are often impaired. Understanding the barriers to exercise in people with difficult asthma is crucial for increasing their activity, and in implementing successful, disease modifying, and holistic approaches to improve their health.
METHODS METHODS
62 Patients within the WATCH Difficult Asthma Cohort (Southampton, UK) completed an Exercise Therapy Burden Questionnaire (ETBQ). The results were analyzed with contemporaneous asthma-related data to determine relationships between perceived exercise barriers and asthma and comorbidity characteristics.
RESULTS RESULTS
Patients were reflective of a difficult asthma cohort, 66% were female, and 63% were atopic. They had a high BMI (median [inter-quartile range]) of 29.3 [25.5-36.2], age of 53.5 [38.75, 65.25], impaired spirometry with FEV1 73% predicted [59.5, 86.6%] and FEV/FVC ratio of 72 [56.5, 78.0] and poor symptom control, as defined by an Asthma Control Questionnaire (ACQ6) result of 2.4 [1.28, 3.2]. A high perceived barriers to exercise score was significantly correlated with increased asthma symptoms (
CONCLUSION CONCLUSIONS
In difficult asthma, perceived barriers to exercise are related to symptom burden and psychological morbidity. Therefore, exercise interventions combined with psychological input such as CBT to restructure thought processes around these perceived barriers may be useful in facilitating adoption of exercise.

Identifiants

pubmed: 32537235
doi: 10.1186/s40733-020-00058-6
pii: 58
pmc: PMC7285728
doi:

Types de publication

Journal Article

Langues

eng

Pagination

5

Subventions

Organisme : Medical Research Council
ID : G0802804
Pays : United Kingdom
Organisme : MRF
ID : MRF_MRF-009-0003-RG-HAITC
Pays : United Kingdom

Informations de copyright

© The Author(s) 2020.

Déclaration de conflit d'intérêts

Competing interestsK.S reports grants from AstraZeneca, grants from Asthma UK, outside the submitted work. T. W reports personal fees and other from MyMHealth, grants from Innovate UK, grants from GSK, grants and personal fees from AstraZeneca, grants and personal fees from Synairgen and personal fees from BI, outside the submitted work. A. F, D. H, C. N, H. M, A. A, D. K, L. P, M. H, HM. H, A. W and R. K report no potential conflicts of interest.

Références

BMJ Open. 2017 Jul 17;7(7):e014580
pubmed: 28716786
Am J Respir Crit Care Med. 2017 Jan 1;195(1):32-42
pubmed: 27744739
BMJ Open. 2017 Jul 10;7(7):e014463
pubmed: 28698320
Prev Med. 2011 Feb;52(2):130-2
pubmed: 21130803
Disabil Health J. 2019 Apr;12(2):278-286
pubmed: 30446481
Arch Phys Med Rehabil. 2017 Nov;98(11):2188-2195.e6
pubmed: 28427927
Eur Respir J. 2020 Jul 30;56(1):
pubmed: 32350100
Biol Psychol. 2018 Mar;133:79-84
pubmed: 29408464
Am Rev Respir Dis. 1992 Apr;145(4 Pt 1):741-5
pubmed: 1554194
Pediatr Pulmonol. 2019 Jul;54(7):962-969
pubmed: 30887727
Eur Respir J. 2016 Jul;48(1):216-28
pubmed: 27230448
Psychol Med. 2016 Oct;46(14):2869-2881
pubmed: 27502153
Curr Opin Pulm Med. 2020 Jan;26(1):56-61
pubmed: 31724962
Patient Educ Couns. 2020 Apr;103(4):682-692
pubmed: 31859120
J Asthma. 2018 Aug;55(8):868-876
pubmed: 28853952
Eur Respir J. 1999 May;13(5):1198-208
pubmed: 10414427
J Asthma. 2006 Mar;43(2):137-43
pubmed: 16517430
BMC Sports Sci Med Rehabil. 2019 Aug 14;11:16
pubmed: 31428433
Am J Mens Health. 2017 Mar;11(2):330-343
pubmed: 27923963
Afr Health Sci. 2016 Dec;16(4):1078-1088
pubmed: 28479901
J Asthma. 2010 Mar;47(2):185-91
pubmed: 20170327
BMC Pulm Med. 2019 May 24;19(1):99
pubmed: 31126281
Am J Respir Crit Care Med. 2020 Jan 1;201(1):83-94
pubmed: 31461630
Cogent Med. 2019;6(1):
pubmed: 31754624
J Allergy Clin Immunol Pract. 2018 Nov - Dec;6(6):1968-1981.e2
pubmed: 29510231
Ann Thorac Med. 2011 Jan;6(1):1-2
pubmed: 21264163
Scand J Med Sci Sports. 1998 Feb;8(1):27-32
pubmed: 9502307
Eur Respir Rev. 2020 Jul 3;29(156):
pubmed: 32620584
Thorax. 2018 Feb;73(2):116-124
pubmed: 28918400
Thorax. 2015 Jun;70(6):589-91
pubmed: 25918120
Med Clin (Barc). 2018 Jun 8;150(11):428-431
pubmed: 29325809
Sports Med. 2014 Dec;44(12):1749-61
pubmed: 25129699

Auteurs

Anna T Freeman (AT)

Clinical & Experimental Sciences, University of Southampton Faculty of Medicine, Southampton General Hospital, Southampton, UK.
Wessex Investigational Sciences Hub, University of Southampton Faculty of Medicine, Southampton General Hospital, Southampton, UK.
Southampton NIHR Respiratory Biomedical Research Centre, Southampton General Hospital, Southampton, UK.

David Hill (D)

Clinical & Experimental Sciences, University of Southampton Faculty of Medicine, Southampton General Hospital, Southampton, UK.
Southampton NIHR Respiratory Biomedical Research Centre, Southampton General Hospital, Southampton, UK.

Colin Newell (C)

Southampton NIHR Respiratory Biomedical Research Centre, Southampton General Hospital, Southampton, UK.

Helen Moyses (H)

Clinical & Experimental Sciences, University of Southampton Faculty of Medicine, Southampton General Hospital, Southampton, UK.
Southampton NIHR Respiratory Biomedical Research Centre, Southampton General Hospital, Southampton, UK.

Adnan Azim (A)

Clinical & Experimental Sciences, University of Southampton Faculty of Medicine, Southampton General Hospital, Southampton, UK.
Southampton NIHR Respiratory Biomedical Research Centre, Southampton General Hospital, Southampton, UK.
Asthma, Allergy and Clinical Immunology Department, University Hospital Southampton NHS Foundation Trust, Southampton, UK.

Deborah Knight (D)

Wessex Investigational Sciences Hub, University of Southampton Faculty of Medicine, Southampton General Hospital, Southampton, UK.
Southampton NIHR Respiratory Biomedical Research Centre, Southampton General Hospital, Southampton, UK.

Laura Presland (L)

Southampton NIHR Respiratory Biomedical Research Centre, Southampton General Hospital, Southampton, UK.

Matthew Harvey (M)

Southampton NIHR Respiratory Biomedical Research Centre, Southampton General Hospital, Southampton, UK.

Hans Michael Haitchi (HM)

Clinical & Experimental Sciences, University of Southampton Faculty of Medicine, Southampton General Hospital, Southampton, UK.
Southampton NIHR Respiratory Biomedical Research Centre, Southampton General Hospital, Southampton, UK.
Asthma, Allergy and Clinical Immunology Department, University Hospital Southampton NHS Foundation Trust, Southampton, UK.
Institute for Life Sciences, University of Southampton, Southampton, UK.

Alastair Watson (A)

Clinical & Experimental Sciences, University of Southampton Faculty of Medicine, Southampton General Hospital, Southampton, UK.
Wessex Investigational Sciences Hub, University of Southampton Faculty of Medicine, Southampton General Hospital, Southampton, UK.
Southampton NIHR Respiratory Biomedical Research Centre, Southampton General Hospital, Southampton, UK.

Karl J Staples (KJ)

Clinical & Experimental Sciences, University of Southampton Faculty of Medicine, Southampton General Hospital, Southampton, UK.
Wessex Investigational Sciences Hub, University of Southampton Faculty of Medicine, Southampton General Hospital, Southampton, UK.
Southampton NIHR Respiratory Biomedical Research Centre, Southampton General Hospital, Southampton, UK.

Ramesh J Kurukulaaratchy (RJ)

Clinical & Experimental Sciences, University of Southampton Faculty of Medicine, Southampton General Hospital, Southampton, UK.
Southampton NIHR Respiratory Biomedical Research Centre, Southampton General Hospital, Southampton, UK.
Asthma, Allergy and Clinical Immunology Department, University Hospital Southampton NHS Foundation Trust, Southampton, UK.
The David Hide Asthma & Allergy Research Centre, St Mary's Hospital, Newport, Isle of Wight UK.

Tom M A Wilkinson (TMA)

Clinical & Experimental Sciences, University of Southampton Faculty of Medicine, Southampton General Hospital, Southampton, UK.
Wessex Investigational Sciences Hub, University of Southampton Faculty of Medicine, Southampton General Hospital, Southampton, UK.
Southampton NIHR Respiratory Biomedical Research Centre, Southampton General Hospital, Southampton, UK.

Classifications MeSH